Affiliation: University of Maryland
- The evolving role of postoperative adjuvant radiation therapy for pancreatic cancerMichael C Garofalo
Department of Radiation Oncology, University of Maryland at Baltimore, 22 South Green Street, Baltimore, MD 21201, USA
Surg Oncol Clin N Am 13:589-604, viii. 2004..Implications of the recently completed intergroup study are discussed, modern radiation therapy delivery techniques are reviewed, and suggestions for future trials are made...
- The case for adjuvant chemoradiation for pancreatic cancerMichael Garofalo
Department of Radiation Oncology, University of Maryland Medical Center, 22 S Greene Street, Baltimore, MD 21201, USA
Best Pract Res Clin Gastroenterol 20:403-16. 2006..Modern radiotherapy delivery techniques will also be discussed and future trial designs suggested...
- Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancersSusannah Yovino
Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Int J Radiat Oncol Biol Phys 79:158-62. 2011..Whether these improved dose distributions are associated with decreased toxicity when compared with conventional three-dimensional treatment remains a subject of investigation...
- Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasoundSusannah Yovino
Department of Radiation Oncology, University of Maryland School of Medicine, 22 S Greene St, Baltimore, MD 21201, USA
J Gastrointest Surg 11:36-42. 2007..A standardized method for predicting unresectability in pancreatic cancer has not been defined. We propose a system using CT and endoscopic ultrasound (EUS) to assess patients for unresectable pancreatic cancers...
- The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiationThomas J MacVittie
Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, MD 21201, USA
Health Phys 103:427-53. 2012..Specific and multi-organ medical countermeasures can be assessed for efficacy and interaction during the concomitant evolution of acute and delayed key organ-specific subsyndromes...
- Radiation oncology emergenciesYoung Kwok
Department of Radiation Oncology, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA
Hematol Oncol Clin North Am 20:505-22. 2006..When radiation therapy is used, the total dose and fractionation schedule should be tailored to the disease setting and life expectancy of the patient...
- Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directionsMichael T Milano
Department of Cellular and Radiation Oncology, University of Chicago, Chicago, IL 60637, USA
Int J Oncol 28:1141-51. 2006..Building on the present clinical experience, future directions include more directed efforts at reducing toxicity, with better planning software and planning techniques...
- On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancerMichael C Garofalo
Ann Surg 244:332-3; author reply 333. 2006
- Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigmWilliam F Regine
Department of Radiation Oncology, University of Maryland, Baltimore, MD, USA
Int J Radiat Oncol Biol Phys 68:172-7. 2007..To determine the maximum tolerated dose of upper abdominal low-dose fractionated radiotherapy (<1.0 Gy per fraction) given in combination with, and as a chemopotentiator for, gemcitabine...
- Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcomeMichael T Milano
Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
Int J Radiat Oncol Biol Phys 59:445-53. 2004..To assess the efficacy and toxicity of intensity-modulated radiotherapy (IMRT) in pancreatic and bile duct (cholangiocarcinoma) malignancies...
- Primary MALT lymphoma of the gallbladder. Case reportMatthew Koshy
Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA
J Gastrointestin Liver Dis 17:207-10. 2008..When the disease is localized to the gallbladder, primary MALT lymphomas of the gallbladder carry an excellent prognosis, and surgical resection is curative in the majority of cases...
- Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive reviewJohnny Kao
Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA
Cancer Treat Rev 29:21-30. 2003..The results of reirradiation in recurrent head and neck cancer and the prognostic factors predicting outcome in this patient population are reviewed...
- Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancerMichael C Garofalo
University of Chicago, Department of Radiation and Cellular Oncology, Chicago, Illinois 60637, USA
Curr Opin Oncol 14:330-3. 2002..This article provides a rationale for management and reviews recent results of reirradiation...